scholarly journals Ultrasonic Testing of Clinical Effect of Bicyclol on Liver Function Impairment Induced by Antithyroid Drugs

2020 ◽  
Vol 82 (s1) ◽  
Author(s):  
Y. MIAO
Keyword(s):  
Liver Function ◽  
Ultrasonic Testing ◽  
Clinical Effect ◽  
Antithyroid Drugs ◽  
Liver Function Impairment ◽  
Function Impairment

Reverse flow in intrahepatic portal vessels and liver function impairment in cirrhosis

1997 ◽  
Vol 6 (3) ◽  
pp. 171-177 ◽  
Author(s):  
L Tarantino ◽  
A Giorgio ◽  
G de Stefano ◽  
N Mariniello ◽  
A Perrotta ◽  
...  
Keyword(s):  
Liver Function ◽  
Reverse Flow ◽  
Liver Function Impairment ◽  
Function Impairment

Individual diagnosis of chemotherapy-associated liver function impairment before surgery of hepatic colorectal metastases

2017 ◽  
Vol 72 ◽  
pp. S65
Author(s):  
J.F. Lock ◽  
T. Westphal ◽  
M. Malinowski ◽  
M. Jara ◽  
J. Bednarsch ◽  
...  
Keyword(s):  
Liver Function ◽  
Colorectal Metastases ◽  
Liver Function Impairment ◽  
Function Impairment

scholarly journals The feasibility of transcatheter arterial chemoembolization following radiation therapy for hepatocellular carcinoma

2021 ◽  
Vol 10 (7) ◽  
pp. 205846012110349
Author(s):  
Mostafa Hamada ◽  
Eisuke Ueshima ◽  
Takeaki Ishihara ◽  
Yutaka Koide ◽  
Takuya Okada ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Function ◽  
Transcatheter Arterial Chemoembolization ◽  
Survival Duration ◽  
High Dose ◽  
Short Term ◽  
Liver Function Impairment ◽  
Function Impairment ◽  
Short Term Mortality ◽  
Arterial Chemoembolization

Background Technological developments have led to an increased usage of external-body radiotherapy (RT) for the treatment of hepatocellular carcinoma (HCC). Transcatheter arterial chemoembolization (TACE) may be required later in patients treated with RT because of the high recurrence rate and multinodular presentation of HCC. However, despite the risk of liver function impairment, the cumulative liver damage correlated with TACE following a hepatic RT has not been adequately assessed. Purpose To evaluate the feasibility of TACE following RT for HCC. Materials and methods Sixty-seven patients with HCC who underwent TACE after RT were retrospectively evaluated between 2012 and 2018. We assessed increases in Child–Turcotte–Pugh (CTP) by ≥2 points at 1 month, the incidence of major complications, survival duration, and short-term mortality within 6 months after TACE. Furthermore, we evaluated the predictive factors for liver function impairment and short-term mortality. Results Eight patients experienced a CTP increase ≥2 points at 1 month. There were no cases of liver abscesses or bilomas. Nine patients died within 6 months following TACE. The mean liver dose (MLD) was a significant predictor of liver function impairment at 1 month ( p = 0.042). Low liver functional reserve, distant metastasis ( p = 0.037), MLD ( p = 0.046), TACE type ( p = 0.025), and TACE within 3 months following RT ( p = 0.007) were significant predictors of short-term mortality. Conclusions Despite the feasibility of TACE following RT, clinicians should pay attention to impaired pretreatment liver function, following high dose RT, and the short duration between RT and TACE.

scholarly journals Delayed Liver Function Impairment Secondary to Interferon �-1a Use in Multiple Sclerosis

2013 ◽  
Vol 5 (2) ◽  
pp. 130-135 ◽  
Author(s):  
Ming-Feng Liao ◽  
Su-Chen Yen ◽  
Chun-Yen Lin ◽  
Rong-Kuo Lyu
Keyword(s):  
Multiple Sclerosis ◽  
Liver Function ◽  
Liver Function Impairment ◽  
Function Impairment

scholarly journals Alteration of Liver Function in Preeclampsia and Eclampsia

2013 ◽  
Vol 12 (3) ◽  
pp. 9-10
Author(s):  
Dilip Kumar Bhowmik ◽  
Rafia Akhtari ◽  
Sadhu Uttam Kumar ◽  
Madhusudan Saha ◽  
Dipal Krishna Adhikary
Keyword(s):  
Alkaline Phosphatase ◽  
Liver Function ◽  
Serum Bilirubin ◽  
Reference Value ◽  
Normal Pregnancy ◽  
Fetal Outcome ◽  
Medical College ◽  
Liver Function Impairment ◽  
Function Impairment ◽  
Normal Reference Value

Introduction: Abnormal liver function in patients with PET and eclampsia affect both maternal and fetal outcome negatively. This study was done to see change of liver function in comparison to normal pregnancy and normal reference value. Methods: Consecutive 47 patients of PET and eclampsia were taken as cases and 35 normal expectant mother were enrolled as controls. ALT, AST, alkaline phosphatase, serum bilirubin, serum creatinine and urine for albumin of patients andnormal pregnant women were tested and compared. Results: ALT, AST, S. Bilirubin, Alkaline phoshatase levels were elevated with more proteinuria among patients with PET and eclampsia, but ALT and alkaline phosphatase levels and level of proteinuria were significantly higher. Conclusions: Liver function impairment is very common in pre-eclampsia and eclampsia.Chattagram Maa-O-Shishu Hospital Medical College Journal Volume 12, Issue 3, September 2013: 9-10

Sign in / Sign up

Export Citation Format

Share Document